DuPont de Nemours, Inc.
No SEC Form 4 filings for $DD in the last 30 days.
See all $DD insider activity →DoubleDragon Corp. reported H1 core net income up 162% to PHP 2.41 billion and revenues up 23% to PHP 8.55 billion, citing faster core revenue growth as it shifts from fair value gains to recurring operating income. It plans multiple mall, warehouse, and Hotel101 openings in H2 and a SGD 300 million REIT vehicle for Hotel101 projects.
Simply Wall St reports DuPont de Nemours (DD) posted Q2 2026 sales of $1,819 million and net income of $143 million, and raised full-year sales guidance. The article cites DD shares up 8.11% over one month and 19.29% YTD, and discusses valuation versus a $172.07 fair value estimate, plus PFAS legal risk and China-linked electronics demand.
California Attorney General Rob Bonta filed an amended complaint alleging DuPont and related spin-offs used corporate restructurings to shift PFAS cleanup liabilities and keep assets out of reach. The filing targets New DuPont, Corteva, Chemours and Qnity Electronics, citing a 2015 Chemours spin-off, a $4 billion PFAS liability cap, and alleged insurance asset transfers. The case remains active in U.S. District Court.
Over the past 7 days, alphai's AI scored 7 news stories mentioning DD (DuPont de Nemours, Inc.). Coverage has skewed bullish: 4 bullish, 0 neutral, and 3 bearish.
Recent DD coverage spans regulation, earnings and financial news.
H1 earnings acceleration and a pipeline of new mall, warehouse, supermarket, and Hotel101 openings support a constructive near-to-medium term outlook for core revenue generation.
The article frames DD’s post-results upside versus valuation, but provides no new guidance numbers beyond “higher guidance.”
New allegations of fraudulent restructuring and asset shielding raise tail-risk for DuPont-related entities and could pressure DD risk premium.
If the court accepts fraudulent transfer allegations, DuPont could face increased PFAS liability exposure and asset-unwinding risk tied to its restructuring.
The settlement creates a large, time-phased liability and reinforces ongoing remediation obligations tied to PFAS contamination.
alphai scores every news story that mentions DD with an AI model for sentiment and relevance, and aggregates insider trades from DuPont de Nemours, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
DoubleDragon Corp. reported H1 core net income up 162% to PHP 2.41 billion and revenues up 23% to PHP 8.55 billion, citing faster core revenue growth as it shifts from fair value gains to recurring operating income. It plans multiple mall, warehouse, and Hotel101 openings in H2 and a SGD 300 million REIT vehicle for Hotel101 projects.
4 min readSimply Wall St reports DuPont de Nemours (DD) posted Q2 2026 sales of $1,819 million and net income of $143 million, and raised full-year sales guidance. The article cites DD shares up 8.11% over one month and 19.29% YTD, and discusses valuation versus a $172.07 fair value estimate, plus PFAS legal risk and China-linked electronics demand.
6 min readCalifornia Attorney General Rob Bonta filed an amended complaint alleging DuPont and related spin-offs used corporate restructurings to shift PFAS cleanup liabilities and keep assets out of reach. The filing targets New DuPont, Corteva, Chemours and Qnity Electronics, citing a 2015 Chemours spin-off, a $4 billion PFAS liability cap, and alleged insurance asset transfers. The case remains active in U.S. District Court.
6 min readCalifornia Attorney General Rob Bonta alleges in a federal filing that DuPont and three spin-offs used memorandums of understanding to shift most PFAS liabilities onto Chemours while limiting exposure for Corteva, New DuPont and Qnity. Bonta cites possible fraudulent transfer law violations. DuPont disputes; a prior New Jersey case settled for $2 billion.
6 min readNew Jersey will receive up to $2.5 billion from settlements with DuPont and 3M over PFAS environmental damages, according to The Philadelphia Inquirer. Judge Renée Marie Bumb approved agreements ending a case filed in 2019. 3M to pay $400m-$450m; DuPont-related entities $875m over 25 years, plus $1.2b remediation commitments.
4 min readDuPont de Nemours (NYSE:DD) was selected to provide its MemCor membrane bioreactor system for the upgrade of Australia’s Lower Molonglo Water Quality Control Centre, described as the country’s largest inland wastewater treatment plant. The project aims to support population growth and more resilient water infrastructure, highlighting DuPont Water Solutions’ advanced treatment technology.
2 min readDuPont (DD) reported Q2 2026 net sales of $1.8 billion, up 4% year over year, with organic sales growth of 4%. Operating EBITDA was $448 million, up 5.9%, and operating EBITDA margin rose to 24.6%. Adjusted EPS was $1.88, up 48%. The company raised full-year operating EBITDA guidance and plans a $250 million share repurchase program.
6 min readNewsletter previews a mixed market open after S&P 500’s 3.5% surge to new highs. It cites: Apple downgraded by Jefferies; Intel plans $15B stock sale; Uber price target raised to $110; HPE upgraded by Morgan Stanley; Meta’s Muse Glimmer; upgrades for Dick’s and DuPont (PT $172); and Boeing selling autonomous units to Archer.
6 min readA federal court approved New Jersey’s $2.5 billion settlement with DuPont and 3M over PFAS (“forever chemicals”) contamination, state officials said. The deal resolves New Jersey suits filed in 2019 against DuPont and a separate case against 3M. Up to $365 million will fund site restoration near four locations. Payments are expected annually for 25 years.
5 min readA New Jersey federal judge approved PFAS settlements totaling over $2.5 billion with DuPont, Chemours, Corteva and 3M, Reuters reported. The deals require cleanup of four former sites and compensation for natural-resource damages, including a $1.2 billion restoration fund. DuPont, Chemours and Corteva pay $875 million over 25 years; 3M pays $400-$450 million, plus a $475 million reserve.
5 min read
